Market Access/ News/ News/ News/ News/ Oncology/ Patients/ Top stories NHS saved £324 million by switching to biosimilars and generics Piotr Wnuk biogenerics, biosimilar, generics, NHS, NHS England, NHS finances 0 Comment The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar and generic Share X NHS saved £324 million by switching to biosimilars and generics https://pharmaphorum.com/news/nhs-saved-millions-switching-biosimilars/
Healthcare/ Market Access/ News/ News/ UK & Europe Future of NHS is ‘precarious,’ warns watchdog Andrew McConaghie NHS, NHS finances 0 Comment The independent watchdog for health and social care in England says the country’s NHS faces a ‘precarious’ future Share X Future of NHS is ‘precarious,’ warns watchdog https://pharmaphorum.com/news/future-nhs-precarious-warns-watchdog/
biogenerics, biosimilar, generics, NHS, NHS England, NHS finances
0 Comment
